Clinical Trial Update: A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) [NA]

View source ↗

Summary

A Memorial Sloan Kettering Cancer Center trial is evaluating a plant-based diet in people with Monoclonal Gammopathy of Undetermined Significance or Smoldering …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Smoldering Multiple Myeloma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-02-18